We proudly announce that Moirai Biodesign has been awarded by the EU with the H2020 programme innovative SME phase 1. The aim of the funding is to explore the scientific or technical feasibility and commercial potential of the innovation proposed. Moirai Biodesign's project passed all the criteria in terms of Impact, Excellence and Quality of Implementation. It is a great recognition of the work done so far but also an enourmous stimulus to persevere in the search for patient-oriented improvements of the current health ecosystem.
Thanks to the co-financing of the European Social Fund and the "la Caixa" Banking Foundation, we welcome in our team Dr. Carla Minguet. We are convinced that her undeniable talent is a great added value for Moirai Biodesign. We hope that our scientific challenges will thrill her as much as they excite us. Thank you for betting on (and with) us and helping Moirai Biodesign to grow.
From Moirai Biodesign, we would like to congratulate EADA business school students: Mohamed Al-Lahari, Clara Beyer, Anca Gavra, Arkadiy Golyaev, Paola Gomez Lara and Maria Rocha. Thanks to the supervision of Alexis Mavrommatis, to the coordination of ACCIO by Bernat Font but above all thanks to your effort and dedication you have done a brilliant final work. We know it has been a big challenge, but we enjoyed sharing it with you. Lots of luck for your future.
The development on novel diagnostics and therapies for treating cancer is the mission of Moirai Biodesign, a catalan startup founded on April 2016, which is currently enrolled in the third edition of IndieBio, a startup accelerator program based in Cork (Ireland).
The participants of the most recent edition of Indiebio have been hard at work in Ireland since May 3rd â€“ and now you can take a peek at whatâ€™s going on. (Photo credit: Brendan O'Leary/oleary.photo)
We are proud to announce that our company has been selected to participate in the 2016 edition of the prestigious Indiebio EU accelerator program, hosted by the US based venture capital firm SOSV. SOSV will invest $100,000 and offer a 3-month program that include mentoring from first-class business and scientific advisors.